Want to see INTS full AI Analyst Report?
Intensity Therapeutics, Inc. (INTS) Financial Statements
Intensity Therapeutics, Inc. Financial Overview
Intensity Therapeutics, Inc.'s market cap is currently $11.10M. The company's EPS TTM is $-4.83; its P/E ratio is -0.70; Intensity Therapeutics, Inc. is estimated to report earnings on November 5, 2026, and the estimated EPS forecast is $-0.99. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -26.00K | $ 0.00 | $ -147.00K | $ 0.00 | $ 0.00 |
| Operating Income | $ -11.97M | $ -16.59M | $ -8.32M | $ -7.55M | $ -8.01M |
| EBITDA | $ -11.61M | $ -16.27M | $ -10.09M | $ -7.32M | $ -7.88M |
| Net Income | $ -11.61M | $ -16.27M | $ -10.54M | $ -7.58M | $ -7.90M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 11.92M | $ 2.59M | $ 14.78M | $ 1.31M | $ 4.54M |
| Total Assets | $ 14.10M | $ 4.78M | $ 17.30M | $ 1.76M | $ 5.22M |
| Total Debt | $ 110.00K | $ 138.00K | $ 158.00K | $ 4.49M | $ 2.34M |
| Net Debt | $ -11.81M | $ -2.45M | $ -8.40M | $ 3.18M | $ -2.20M |
| Total Liabilities | $ 2.23M | $ 1.86M | $ 4.13M | $ 16.86M | $ 13.90M |
| Stockholders' Equity | $ 11.88M | $ 2.92M | $ 13.16M | $ -15.10M | $ -8.68M |
| Cash Flow | |||||
| Free Cash Flow | $ -9.23M | $ -15.22M | $ -7.21M | $ -5.48M | $ -6.83M |
| Operating Cash Flow | $ -9.23M | $ -15.22M | $ -7.21M | $ -5.48M | $ -6.83M |
| Investing Cash Flow | $ 0.00 | $ 6.35M | $ -6.02M | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 18.56M | $ 2.90M | $ 20.47M | $ 2.25M | $ 2.05M |
Currency in USD